2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the … T Beukelman, NM Patkar, KG Saag, S Tolleson‐Rinehart, RQ Cron, ... Arthritis care & research 63 (4), 465-482, 2011 | 1141 | 2011 |
Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial B Shakoory, JA Carcillo, WW Chatham, RL Amdur, H Zhao, CA Dinarello, ... Critical care medicine 44 (2), 275-281, 2016 | 891 | 2016 |
2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of … A Ravelli, F Minoia, S Davì, AC Horne, F Bovis, A Pistorio, M Aricò, ... Arthritis & rheumatology 68 (3), 566-576, 2016 | 855 | 2016 |
On the alert for cytokine storm: immunopathology in COVID‐19 LA Henderson, SW Canna, GS Schulert, S Volpi, PY Lee, KF Kernan, ... Arthritis & rheumatology 72 (7), 1059-1063, 2020 | 748 | 2020 |
The immunology of macrophage activation syndrome CB Crayne, S Albeituni, KE Nichols, RQ Cron Frontiers in immunology 10, 433348, 2019 | 619 | 2019 |
Anakinra as first‐line disease‐modifying therapy in systemic juvenile idiopathic arthritis: report of forty‐six patients from an international multicenter series PA Nigrovic, M Mannion, FHM Prince, A Zeft, CE Rabinovich, ... Arthritis & rheumatism 63 (2), 545-555, 2011 | 529 | 2011 |
Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment A Ravelli, AA Grom, EM Behrens, RQ Cron Genes & Immunity 13 (4), 289-298, 2012 | 450 | 2012 |
Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. EM Behrens, T Beukelman, M Paessler, RQ Cron The Journal of rheumatology 34 (5), 1133-1138, 2007 | 438 | 2007 |
Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients F Minoia, S Davì, AC Horne, E Demirkaya, F Bovis, C Li, K Lehmberg, ... Arthritis & rheumatology 66 (11), 3160-3169, 2014 | 433 | 2014 |
MHCII is required for α-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration AS Harms, S Cao, AL Rowse, AD Thome, X Li, LR Mangieri, RQ Cron, ... Journal of Neuroscience 33 (23), 9592-9600, 2013 | 393 | 2013 |
High prevalence of temporomandibular joint arthritis at disease onset in children with juvenile idiopathic arthritis, as detected by magnetic resonance imaging but not by … PF Weiss, B Arabshahi, A Johnson, LT Bilaniuk, D Zarnow, AM Cahill, ... Arthritis & rheumatism 58 (4), 1189-1196, 2008 | 302 | 2008 |
Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive … PM Miettunen, A Narendran, A Jayanthan, EM Behrens, RQ Cron Rheumatology 50 (2), 417-419, 2011 | 301 | 2011 |
Major histocompatibility complex-linked specificity of γδ receptor-bearing T lymphocytes LA Matis, R Cron, JA Bluestone Nature 330 (6145), 262-264, 1987 | 288 | 1987 |
Structure and specificity of T cell receptor gamma/delta on major histocompatibility complex antigen-specific CD3+, CD4-, CD8-T lymphocytes. JA Bluestone, RQ Cron, M Cotterman, BA Houlden, LA Matis The Journal of experimental medicine 168 (5), 1899-1916, 1988 | 281 | 1988 |
Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome P Mehta, RQ Cron, J Hartwell, JJ Manson, RS Tattersall The Lancet Rheumatology 2 (6), e358-e367, 2020 | 261 | 2020 |
Benefit of anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis EM Eloseily, P Weiser, CB Crayne, H Haines, ML Mannion, ML Stoll, ... Arthritis & rheumatology 72 (2), 326-334, 2020 | 251 | 2020 |
Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR). EM Behrens, T Beukelman, L Gallo, J Spangler, M Rosenkranz, ... The Journal of rheumatology 35 (2), 343-348, 2008 | 225 | 2008 |
Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis ML Stoll, R Kumar, CD Morrow, EJ Lefkowitz, X Cui, A Genin, RQ Cron, ... Arthritis research & therapy 16, 1-10, 2014 | 216 | 2014 |
Treatment of juvenile idiopathic arthritis: a revolution in care ML Stoll, RQ Cron Pediatric rheumatology 12, 1-10, 2014 | 215 | 2014 |
An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis S Davì, A Consolaro, D Guseinova, A Pistorio, N Ruperto, A Martini, ... The Journal of rheumatology 38 (4), 764-768, 2011 | 189 | 2011 |